Please login to the form below

Not currently logged in
Email:
Password:

Axon bolsters team with new PR Director hire

Mary Smiddy joins from Tonic Life Communications

Mary SmiddyLondon, UK-based Axon Communications has appointed Mary Smiddy as its new PR director in a role that will see her deliver outcomes-based, integrated communications programmes.

Prior to joining Axon, Smiddy was global chief executive officer at PR agency Tonic Life Communications and before that held roles at the likes of Porter Novelli, Weber Shandwick and GlaxoSmithKline, where she served as a regional communications director.

She said: “Axon is an agency I have long admired in terms of its cohesive culture, scientific rigour and award-winning work.

“Once I met the broader team, I knew I wanted to join this highly intelligent and curious group of individuals who share my passion.”

During her career, Smiddy has led local, regional and international programmes to support pharmaceutical products in numerous therapeutic fields including cardiology, immunology, CNS and oncology.

Miranda Dini, managing partner for Axon, said: “Mary is an energetic and dynamic leader and we are delighted she has become part of the Axon UK family.

“She is joining us at a time of continued growth, and I know her expertise and fresh perspectives will help further accelerate our on-going achievements.”

26th July 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics